Tags: Chronic Pain | FDA | approves | abuse | deterrent | painkiller | Xtampza ER

FDA Approves Abuse-Deterrent Painkiller

Image: FDA Approves Abuse-Deterrent Painkiller
(Copyright DPC)

Wednesday, 27 Apr 2016 08:16 AM

Collegium Pharmaceutical Inc said on Tuesday its abuse-deterrent painkiller won full marketing approval from U.S. health regulators.

The drug, Xtampza ER, won a tentative approval in November, but full approval was contingent on the outcome of a lawsuit filed by Purdue Pharma against Collegium.

Purdue Pharma, which has also developed abuse-deterrent versions of the commonly prescribed and often-abused painkiller Oxycontin, claimed that Xtampza infringed some of its patents.

However, the District Court of Massachusetts in February ruled in favor of Collegium.

Xtampza ER is a long-acting oral opioid painkiller meant to be taken after a meal for maximum effect.

© 2017 Thomson/Reuters. All rights reserved.

 
1Like our page
2Share
Health-News
Collegium Pharmaceutical Inc said on Tuesday its abuse-deterrent painkiller won full marketing approval from U.S. health regulators. The drug, Xtampza ER, won a tentative approval in November, but full approval was contingent on the outcome of a lawsuit filed by Purdue...
FDA, approves, abuse, deterrent, painkiller, Xtampza ER
99
2016-16-27
Wednesday, 27 Apr 2016 08:16 AM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved